Shandong dyne marine biopharmaceutical co., ltd., which was established in October 1994, is a pharmaceutical enterprise specializing in the research and development and production of children's health. Shanda Walter Technology Co., Ltd., the main shareholder of Dyne Pharmaceutical, is the only listed company in Shandong universities controlled by Shandong University (stock code 915). Beijing Dyne Kangjian Pharmaceutical Co., Ltd. and Shandong Dyne Biotechnology Co., Ltd. are wholly-owned subsidiaries.
Dyne Pharmaceutical's existing products mainly involve the fields of children's medicines, foods and articles, forming a pattern of children's health industry with "children's health care and treatment" as the core. The production base in Rongcheng, Shandong Province covers an area of nearly 4 mu, and has many modern production lines and workshops for raw materials such as soft capsules, granules, tablets and oral liquids. It has an annual production capacity of 2 billion soft capsules, 5 million tablets and capsules, 1 billion bags of granules and 1 billion oral liquids, and its production capacity ranks among the top in children's pharmaceuticals.
Diane Pharmaceutical has carried out the research of "tailor-made children's drugs" through scientific and technological innovation, and built the first research and development center for children's drugs in China, with a building area of 8,4 square meters, which has been put into use at present. Since 27, Diane Pharmaceutical Co., Ltd. has approved more than 4 children's drugs, involving the research of drugs for treating common and frequently-occurring diseases and some rare diseases in children, all of which are in special specifications and dosage forms for children, such as oral liquid, granules and transdermal patches. In 211, Dyne Pharmaceutical became a national-level comprehensive new drug research and development technology platform industrialization demonstration enterprise. In 213, it was designated as the "Children's Drug Research Base" by the Economic Information Daily of Xinhua News Agency, which provided support for the formulation of policies on research, development and production of children's drugs in China. In 214, Diane Pharmaceutical cooperated with School of Pharmacy, Shandong University to set up a professional degree postgraduate workstation, and through the combination of "production, learning and research", the level of technological innovation was continuously improved, and the safety of children's medication was defended with professionalism and responsibility.
Diane Pharmaceutical has achieved good coverage in the field of pediatric medicine by relying on professional promotion methods in its business practice, and established a brand image in the children's medicine market, which is deeply trusted by the industry and recognized by consumers. In 28, Yi Kexin? Won the well-known trademark of China, Dyne in 21? Won the famous trademark of Shandong Province, and its star product, Yikexin (vitamin AD drop capsule), has exceeded 7 million yuan in annual sales, ranking first in the market share of similar products for 14 consecutive years. According to the statistics of China Medical Statistics Annual Report published by the Ministry of Industry and Information Technology in 212, the sales revenue and total profit of Dyne Pharmaceutical are among the top 2 chemical pharmaceutical industries in China.
in the course of its operation, dyne pharmaceutical has continuously participated in social welfare and charity, and fulfilled its mission by contributing to the construction of "dyne hope primary school", participating in the "I want to go to school" aid activity in western poverty-stricken areas, and continuing to donate to disaster-stricken areas and destitute children.